RNU7-183P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU7-183P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU7-183P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU7-183P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-183P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

STAD, ESCA, and CESC are the cancer types where RNU7-183P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
STADOSTertileAll0.2470.735.00172view →
ESCADFSTertileIII,IV0.0800.442<.00118view →
CESCOSTertileAll0.1290.588.02218view →
OVOSTertileIII,IV0.9270.676.03018view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU7-183P–STAD (OS)

Kaplan–Meier survival curve for RNU7-183P RNA-high vs -low samples in STAD.

Open the STAD breakdown →

Exploration